Sub-Committee II
Audio and video webcast recordings of public meetings are available at www.parliamentlive.tv for 365 days.
Memorandum by the Academy of Medical Sciences, April 2008
Memorandum by the Advertising Standards Authority, 22 January 2009
Memorandum by the Almac Group, 21 April 2008
Memorandum by the Arts and Humanities Research Council, 21 April 2008
Memorandum by the Association of the British Pharmaceutical Industry, 21 April 2008
Memorandum by the Association for Clinical Cytogenetics, 18 April 2008
Memorandum by the Association of Medical Research Charities, May 2008
Memorandum by Applied Biosystems, December 2008
Memorandum by AstraZeneca Research & Development, 21 April 2008
Memorandum by the Association of British Insurers, December 2008
Supplementary Memorandum by BERR & DIUS, December 2008
Memorandum by the Bexely Care Trust, 21 April 2008
Memorandum by the BioIndustry Association, May 2008
Memornadum by the Biosciences Federation, April 2008
Memorandum by the Breast Cancer Campaign, April 2008
Memorandum by Break Through Breast Cancer, July 2008
Memorandum by the British Association for Applied Nutrition & Nutritional Therapy, 17 April 2008
Memorandum by the British Heart Foundation, 21 April 2008
Memorandum by the British Society for Ecological Medicine, April 2008
Memorandum by the British Society for Haematology, April 2008
Memorandum by the British Society for Human Genetics, April 2008
Memorandum by the British Society for Immunology, April 2008
Memorandum by Cancer Research UK, May 2008
Memorandum by Chordata Research, April 2008
Memorandum by EGENIS, 15 April 2008
Memorandum by the Economic & Social Research Centre, Cesagen, Cardiff & Lancaster Universities, April 2008
Memorandum by the Economic & Social Research Council Genomic Network, 15 April 2008
Memorandum by the Economic & Social Research Centre, Further Submission - Psychiatric Genetics, April 2008
Memorandum by the ESRC Centre for Social and Economic Research on Innovation in Genomics (Innogen), 18th April 2008
Memorandum by the European Bioinformatics Institute, April 2008
Memorandum by the Genetic Interest Group, 11 April 2008
Memorandum by Genetic Health, 25 November 2008
Memorandum by the General Medical Council, 25 November 2008
Memorandum by GenoMed Inc, April 2008
Memorandum by Gen2Phen, June 2008
Memorandum by GeneWatch UK, April 2008
Memorandum by Generation Scotland, April 2008
Memorandum by Genzyme UK & Ireland, 18 April 2008
Memorandum by the Government , April 2008
Supplementary Memorandum by the Government, December 2008
Further Supplementary Memorandum by the Government, 28 April 2009
Memorandum by Professor Mark Hanson, October 2008
Memorandum by the Harvard Medical School Partners HealthCare ,Center for Genetics and Genomics, April 2008
Memorandum by the Hastings Centre, 17 April 2008
Memorandum by the Health & Safety Executive, April 2008
Memorandum by Hogarth and Melzer, April 2008
Memorandum by the Human Genetics Commission, April 2008
Memorandum by the Human Genetics Commission Supplementary Evidence, 3 July 2008
Memorandum by the Human Fertilisation & Embryology Authority, 15 APRIL 2008
Memorandum by the Institute of Medical Genetics, Cardiff, 21 April 2008
Memorandum by the Joint Committee on Medical Genetics, 18 April 2008
Memorandum by LGC Ltd, April 2008
Supplementary Memorandum by Medicines & Healthcare Products Regulatory Agency Government Response, 10 July 2008
Memorandum by the Information Commissioner's Office, 21 April 2008
Memorandum by the Medical Research Council, November 2008
Memorandum by the MHRA, 25 November 2008
Memorandum by the NHS National Genetics Education and Development Centre, University of Glamorgan, 21 April 2008
Memorandum by the NHS National Genetics Education and Development Centre, April 2008
Memorandum by the National Genetics Reference Laboratory Manchester, 21 April 2008
Memorandum by the National Genetics Reference Laboratory (Wessex), April 2008
Memorandum by the National Institute for Health & Clinical Execellence, April 2008
Memorandum by Oxford Nanopore Technologies Ltd, April 2008
Supplementary Memorandum by Oxford Nanopore, 11 June 2008
Memorandum by the PHG Foundation, 17 April 2008
Memorandum by the Research Councils UK, 22 April 2008
Memorandum by Professor Marcus Pembrey, 23 April 2008
Supplementary Memorandum by the PHG Foundation, 22 October 2008
Supplementary Memorandum by the Research Council UK, May 2008
Memorandum by Sir Bruce Ponder, 24 October 2008
Memorandum by Roche, 21 April 2008
Memorandum by Roche Applied Science, 21 April 2008
Memorandum by the Royal Academy of Engineering, April 2008
Memorandum by the Royal College of General Practitioners, 23 April 2008
Supplementary Memorandum by Roche Applied Science, December 2008
Memorandum by the Royal College of Pathologists, 20 April 2008
Memorandum by the Royal College of Physicians, April 2008
Memorandum by the Royal Pharmaceutical Society , 21 April 2008
Memorandum by the UK Genetic Testing Network, April 2008
Supplementary Memorandum by the UK Genetic Testing Network, December 2008
Memorandum by Sheffield Molecular Genetics Service, Sheffields Children NHS Foundation Trust, 30 April 2008
Memorandum by the UK Intellectual Property Office (Report), April 2008
Memorandum by UK Biobank, 15 October 2008
Memorandum by the UK Intellectual Property Office (Annexes), April 2008
Memorandum by the University of Montreal, April 2008
Memorandum by the Trade Union Congress, December 2008
Memorandum by the Wellcome Trust, April 2008
Memorandum by the Wellcome Trust Centre for Human Genetics, 20 April 2008
Memorandum by the Wellcome Trust Sanger Institute, April 2008
Memorandum by Wyeth, April 2008